human
rhinovirus
hrv
wellrecognis
caus
common
cold
associ
upper
respiratori
tract
complic
sinus
otiti
media
articl
review
inform
link
hrv
infect
ill
lower
respiratori
tract
hrv
capabl
effici
replic
vitro
temperatur
present
tracheobronchi
tree
shown
caus
product
infect
elabor
cytokin
chemokin
upregul
cell
surfac
marker
human
bronchial
epitheli
cell
situ
hybridis
studi
proven
hrv
infect
occur
tracheobronchi
tree
follow
experiment
infect
clinic
studi
report
hrv
infect
second
frequent
recognis
agent
associ
pneumonia
bronchiol
infant
young
children
commonli
caus
exacerb
preexist
airway
diseas
asthma
chronic
obstruct
pulmonari
diseas
cystic
fibrosi
hrv
infect
associ
onethird
onehalf
asthma
exacerb
depend
age
link
asthma
hospitalis
adult
children
limit
inform
implic
hrv
infect
caus
sever
lower
respiratori
tract
ill
older
adult
highli
immunocompromis
host
particularli
bone
marrow
transplant
recipi
inform
need
pathogenesi
hrv
infect
regard
lower
respiratori
tract
complic
divers
patient
group
given
larg
unmet
medic
need
associ
hrv
infect
safe
effect
antivir
agent
need
prevent
treatment
infect
human
rhinovirus
hrv
common
caus
upper
respiratori
tract
infect
adult
children
adult
hrv
infect
account
approxim
common
cold
annual
basi
high
preval
autumn
period
northern
hemispher
larg
epidemiolog
studi
report
higher
incid
infect
children
adult
almost
children
experienc
least
one
hrv
infect
age
year
report
associ
hrv
infect
exacerb
chronic
bronchiti
tabl
also
describ
croup
bronchiti
bronchopneumonia
children
hrv
infect
one
earli
report
suggest
hrv
could
caus
atyp
pneumonia
young
adult
recent
evid
increasingli
indic
hrv
infect
import
caus
exacerb
multipl
type
preexist
airway
disord
directli
invad
lower
respiratori
tract
caus
diseas
articl
review
select
studi
address
pathogenesi
epidemiolog
clinic
import
rhinoviru
lower
respiratori
tract
pathogen
nearli
year
ago
studi
experiment
induc
hrv
infect
found
small
particl
aerosol
mm
deliveri
rel
low
dose
tissu
cultur
infecti
dose
tcid
one
hrv
strain
nasal
inhal
consist
induc
infect
well
rhiniti
cough
eight
seroneg
healthi
adult
ill
manifest
tracheobronch
six
frequent
cough
substern
chest
pain
tracheal
tender
two
instanc
wheez
comparison
coryz
ill
common
tracheobronch
occur
two
volunt
intranas
inocul
coars
spray
drop
earli
clinic
observ
link
rhinoviru
infect
exacerb
chronic
bronchiti
adult
acut
wheezi
bronchiti
children
studi
also
document
recoveri
rhinoviru
sputum
sampl
often
upper
respiratori
tract
sampl
exampl
one
prospect
studi
chronic
bronchiti
patient
found
onehalf
cold
preced
follow
exacerb
rhinovirus
recov
nasal
wash
throat
swab
andor
sputum
ill
affect
chest
isol
sputum
five
instanc
includ
three
throat
swab
sampl
neg
titr
high
tcid
ml
although
hrv
gener
temperaturerestrict
replic
optim
growth
c
temperatur
observ
tracheobronchi
tree
often
lower
bodi
core
temperatur
permiss
hrv
replic
direct
monitor
airstream
temperatur
perform
six
healthi
adult
use
multipl
thermistor
six
point
trachea
beyond
subsegment
bronchi
differ
condit
quiet
breath
room
air
c
mean
inspiratori
temperatur
gradual
increas
c
carina
c
distal
high
level
ventil
quiet
breath
cold
air
c
associ
approxim
c
decreas
temperatur
proxim
site
expir
heat
continu
transfer
back
bronchial
mucosa
mean
temperatur
decreas
c
peripheri
c
near
glotti
increas
ventil
rate
inspir
colder
therefor
drier
air
condit
inspir
air
take
place
lower
airway
expir
cool
respiratori
mucosa
occur
facilit
heat
recoveri
lower
airway
temperatur
would
support
hrv
replic
mani
hrv
serotyp
clinic
strain
replic
effici
core
bodi
temperatur
one
vitro
studi
found
serial
growth
seven
eight
hrv
serotyp
modestli
less
product
log
tcid
differ
infecti
titr
hela
cell
monolay
maintain
c
compar
c
furthermor
four
eight
wildtyp
virus
recov
nasal
lavag
replic
well
one
effici
higher
temperatur
compar
c
evid
correl
temperaturerel
differ
replic
upper
lower
ill
found
small
sampl
anoth
studi
found
slightli
lower
hrv
titr
human
bronchial
epitheli
cell
log
tcid
c
c
two
serotyp
vitro
studi
establish
hrv
well
respiratori
virus
capabl
infect
human
respiratori
epitheli
cell
line
vitro
induc
proinflammatori
cytokin
chemokin
releas
exposur
human
respiratori
epitheli
cell
line
deriv
bronchial
epithelium
transform
adenoviru
hybrid
viru
rhinoviru
result
product
viral
replic
least
h
increas
product
gmcsf
without
effect
cell
viabil
elabor
maxim
h
higher
control
correl
viral
titr
cytokin
releas
requir
activ
replic
inhibit
viral
infect
antibodi
use
uv
lightinactiv
viru
block
increas
infect
ineffici
associ
chang
express
enhanc
preexposur
tnfalpha
decreas
exposur
ifnalpha
gamma
exposur
cell
transform
human
alveolar
cell
line
rhinoviru
result
noncytolyt
product
infect
prolong
increas
releas
replic
nonsustain
peak
titr
log
tcid
rhinoviru
lower
respiratori
tract
rhinoviru
lower
respiratori
tract
h
releas
continu
day
infect
prevent
hrv
receptor
bind
solubl
complet
block
replic
cytokin
releas
wherea
exposur
uv
lightinactiv
viru
decreas
releas
sever
hrv
serotyp
shown
replic
primari
human
bronchial
epitheli
cell
caus
cytopath
effect
certain
condit
induc
product
gmcsf
rant
regul
activ
normal
cell
express
secret
hrv
type
magnitud
kinet
ex
vivo
replic
found
similar
primari
adenoid
bronchial
epitheli
cell
although
infect
occur
much
less
often
cell
type
compar
hela
cell
consist
find
scanti
foci
replic
nasal
mucos
biopsi
situ
hybridis
follow
experiment
infect
human
viral
infect
document
infecti
center
immunohistochem
assay
less
expos
cell
despit
use
high
viral
inocula
one
explan
low
proport
infect
cell
may
find
less
effici
eclips
mechan
less
uncoat
attach
viru
perhap
due
pauciti
receptor
surfac
bronchial
epitheli
cell
inflammatori
condit
includ
hrv
infect
upregul
express
could
theoret
enhanc
likelihood
lower
respiratori
tract
replic
perhap
even
foster
initi
infect
follow
inhal
droplet
lower
respiratori
tract
natur
occur
cold
like
lower
respiratori
tract
inocul
infecti
droplet
upper
airway
possibl
bout
cough
sneez
sleep
studi
experiment
infect
volunt
suggest
hrv
replic
lower
airway
usual
without
visibl
chang
bronchial
mucosa
possibl
contamin
upper
airway
exclud
studi
follow
experiment
infect
intranas
instil
viru
hrv
cultur
protect
bronchial
brush
sampl
subject
posit
nasal
sampl
five
clinic
ill
includ
cough
bronchoscopi
specimen
titr
similar
observ
nasal
brush
sampl
viru
recov
bronchoscopi
five
infect
volunt
without
ill
follow
inocul
intranas
instil
larg
particl
aerosol
hrv
rna
detect
lower
airway
secret
cell
rtpcr
directli
situ
hybridis
eight
allerg
volunt
inocul
intranas
coars
aerosol
hrv
viral
rna
detect
nasal
lavag
lower
airway
cell
day
infect
subject
rna
detect
rtpcr
assay
three
eight
acellular
bal
sampl
comparison
airway
cellular
sampl
suggest
larg
cellassoci
posit
result
less
like
due
contamin
upper
airway
ten
adult
experiment
inocul
hrv
intranas
drop
aerosol
replic
form
viral
rna
detect
bronchial
epitheli
biopsi
four
subject
find
establish
hrv
replic
occur
lower
airway
although
frequenc
durat
extent
direct
viral
involv
pathogenet
consequ
remain
defin
natur
circumst
whether
rhinovirus
replic
alveolar
pneumocyt
also
remain
establish
howev
experiment
infect
healthi
volunt
bronchial
biopsi
specimen
show
increas
posit
cell
increas
number
cyclooxygenas
posit
cell
increas
macrophag
mast
cell
well
doubl
bal
fluid
cysteinyl
leukotrien
level
find
indic
hrv
infect
caus
bronchial
inflamm
enhanc
express
pathway
protein
make
potenti
target
therapeut
intervent
studi
hrv
infect
associ
lower
respiratori
tract
ill
hospitalis
across
age
spectrum
exampl
one
prospect
studi
includ
children
adult
hospitalis
variou
acut
respiratori
ill
found
hrv
infect
viru
isol
nose
andor
throat
swab
children
year
age
year
adult
age
year
common
diagnos
young
children
asthma
bronchiol
possibl
sepsi
pneumonia
asthma
princip
reason
admiss
age
year
wherea
pneumonia
congest
heart
failur
chf
chronic
obstruct
airway
diseas
copd
exacerb
asthma
admit
diagnos
older
adult
averag
length
hospit
stay
day
mani
studi
utilis
viru
isol
detect
hrv
infect
thu
underestim
contribut
impact
hrv
infect
also
underestim
mani
studi
conduct
outsid
high
hrv
preval
period
short
period
observ
although
hrv
caus
infect
yearround
peak
preval
period
earli
fall
late
spring
month
northern
hemispher
consequ
studi
focus
winter
month
accur
reflect
rel
contribut
hrv
ill
annual
basi
exampl
hrv
rna
detect
adult
present
influenzalik
ill
fever
respiratori
plu
system
symptom
one
influenza
season
although
found
ill
among
subset
person
aetiolog
establish
standard
method
appreci
epidemiolog
clinic
import
hrv
infect
enhanc
sensit
viral
diagnost
test
specif
applic
rtpcr
test
limit
diagnosi
rtpcr
uncertainti
preval
asymptomat
infect
durat
hrv
rna
detect
upper
respiratori
tract
children
adult
exampl
older
epidemiolog
studi
isol
rhinovirus
respiratori
sampl
collect
well
adult
higher
proport
appar
well
children
one
studi
asymptomat
elderli
adult
found
hrv
rna
upper
respiratori
sampl
wherea
anoth
studi
group
asthmat
adult
found
posit
routin
sampl
studi
stabl
copd
patient
found
hrv
rna
baselin
studi
asthmat
children
age
year
found
posit
rtpcr
assay
picornaviru
sampl
collect
asymptomat
period
recent
studi
asthmat
children
found
hrv
rna
nasopharyng
aspir
collect
clinic
well
anoth
survey
children
age
month
year
without
respiratori
symptom
time
admiss
surgeri
detect
hrv
rna
enteroviru
rna
nasopharyng
sampl
howev
posit
children
recent
experienc
respiratori
symptom
contact
household
member
concurr
symptom
other
develop
symptom
sampl
overal
appar
healthi
children
without
previou
incipi
respiratori
symptom
picornaviru
rna
posit
bronchiol
pneumonia
common
syndrom
children
age
year
admit
hospit
hrv
infect
tabl
prospect
studi
infant
approxim
age
month
less
hospitalis
found
nasopharyng
aspir
cultur
posit
rhinoviru
ill
second
rsv
hrv
especi
import
infant
age
month
associ
lower
respiratori
ill
pneumonia
often
rsv
review
infant
day
age
hospit
viral
pneumonia
found
hrv
cultur
enterovirus
compar
rsv
retrospect
hospitalbas
studi
hrv
cultureposit
paediatr
patient
month
age
younger
found
acut
lower
respiratori
ill
fever
suspect
sepsi
fifteen
chest
radiograph
interstiti
lobar
pneumonia
five
children
requir
ventilatori
support
overal
consid
otherwis
healthi
major
one
underli
condit
includ
prematur
reactiv
airway
congenit
cardiac
diseas
anoth
studi
infant
young
children
bronchopulmonari
dysplasia
identifi
eight
case
sever
cultur
proven
hrv
lower
respiratori
ill
three
nosocomi
acquir
among
patient
hrv
second
rsv
frequenc
less
often
associ
need
mechan
ventil
one
prospect
studi
examin
otherwis
healthi
children
age
month
rhinoviru
lower
respiratori
tract
rhinoviru
lower
respiratori
tract
younger
hospitalis
clinic
diagnosi
bronchiol
found
viral
infect
patient
rtpcr
among
document
viral
infect
rsv
detect
hrv
adenoviru
influenza
parainfluenza
coronaviru
compar
infant
rsv
infect
alon
hrv
infect
alon
hospitalis
earlier
ill
cours
versu
day
somewhat
older
versu
month
hrv
infect
associ
higher
clinic
sever
score
admiss
studi
infant
hospitalis
bronchiol
found
picornaviru
rna
nasal
aspir
compar
sampl
posit
rsv
picornaviru
viru
identifi
ill
anoth
studi
period
rsv
influenza
circul
found
evid
picornaviru
infect
rtpcr
nasopharyng
secret
predomin
hrv
infant
admit
bronchiol
compar
rsv
recent
studi
children
age
month
year
hospitalis
acut
expiratori
wheez
bronchiol
wheezi
bronchiti
asthma
utilis
rtpcr
detect
hrv
enteroviru
nontyp
picornaviru
nearli
twothird
episod
associ
picornaviru
infect
frequenc
primari
viral
pneumonia
secondari
bacteri
infect
associ
hrv
infect
infant
young
children
well
characteris
one
prospect
studi
cultur
hrv
children
pneumonia
almost
age
year
less
prospect
finnish
studi
children
age
year
less
age
year
hospitalis
radiograph
document
communityacquir
pneumonia
cap
utilis
antigen
rtpcr
assay
nasopharyng
aspir
well
viral
cultur
pair
serolog
studi
examin
role
pathogen
potenti
caus
agent
detect
patient
viral
infect
bacteri
infect
three
commonli
detect
agent
pneumonia
rsv
hrv
onehalf
viral
infect
evid
concomit
bacteri
infect
hrv
infect
evid
concomit
bacteri
infect
serolog
test
compar
rsv
infect
one
retrospect
studi
hospitalis
children
cultureproven
hrv
infect
found
concurr
infect
respiratori
virus
four
bacteri
infect
four
other
direct
evid
hrv
invas
pulmonari
parenchyma
found
individu
paediatr
patient
pneumonia
viru
isol
bronchoalveolar
lavag
bal
immunohistochemistri
lung
tissu
one
case
latter
case
fatal
diseas
infant
found
histolog
evid
hyperplasia
desquam
alveolar
line
cell
localis
hrv
antigen
alveolar
epitheli
cell
macrophag
anoth
case
report
describ
recoveri
hrv
postmortem
lung
blood
asthmat
child
die
suddenli
found
necropsi
find
eosinophil
bronchial
inflamm
plug
interstiti
pneumonia
hyalin
membran
sever
tracheobronch
aggreg
avail
evid
suggest
hrv
second
commonli
recognis
viral
caus
bronchiol
pneumonia
infant
young
children
rsv
uncommonli
may
associ
sever
viral
pneumon
well
secondari
bacteri
infect
remain
determin
whether
ill
predispos
subsequ
risk
wheez
asthma
hrv
infect
one
frequent
pathogen
implic
dual
respiratori
viral
infect
also
hypothesis
dual
viral
infect
particularli
relat
picornavirus
adenovirus
could
enhanc
ill
sever
although
remain
definit
establish
one
bronchiol
studi
combin
virus
detect
often
dual
infect
rsv
hrv
instanc
nearli
onehalf
hrv
infect
one
viru
detect
significantli
greater
diseas
sever
admiss
group
patient
dual
infect
admit
later
diseas
cours
singl
pathogen
find
suggest
sequenti
infect
anoth
studi
bronchiol
hospitalis
children
found
dual
viral
infect
children
includ
picornaviru
f
g
hayden
f
g
hayden
infect
evid
greater
sever
ill
compar
singl
infect
unclear
hospitalbas
studi
whether
dual
infect
increas
sever
ill
subsequ
likelihood
hospitalis
extens
analysi
respiratori
viral
studi
identifi
dual
infect
ill
across
age
spectrum
diagnost
method
major
variabl
proport
dual
infect
increas
studi
employ
rtpcr
influenza
hrv
commonli
implic
virus
likelihood
higher
infant
patient
dual
infect
like
hospitalis
infect
due
singl
viru
ambulatori
elderli
person
hrv
infect
experi
high
frequenc
prolong
ill
lower
respiratori
tract
symptom
particularli
underli
airway
diseas
hrv
outbreak
among
elderli
resid
longterm
care
facil
proven
hrv
infect
associ
lower
respiratori
symptom
system
symptom
auscultatori
chang
requir
bronchodil
therapi
one
develop
radiograph
document
pneumonia
anoth
die
respiratori
failur
underli
lung
diseas
like
develop
dyspnoea
bronchospasm
protract
cough
one
prospect
studi
ambulatori
adult
age
year
detect
hrv
rna
respiratori
ill
two
winter
season
among
first
sole
hrv
infect
median
durat
ill
day
lower
respiratori
tract
symptom
product
cough
wheez
chest
pain
unabl
perform
routin
activ
confin
bed
consult
physician
one
die
exacerb
copd
presenc
chronic
medic
condit
smoke
increas
likelihood
lower
respiratori
ill
approxim
elderli
adult
hrv
infect
author
estim
hrv
infect
caus
greatest
overal
diseas
burden
exceed
influenza
respiratori
virus
singl
winter
season
studi
novemberapril
elderli
adult
age
year
hospitalis
clinic
diagnosi
acut
respiratori
ill
includ
pneumonia
copd
exacerb
bronchiti
chf
found
evid
hrv
infect
rtpcr
five
randomli
select
nasopharyng
sampl
patient
neg
influenza
rsv
infect
two
five
radiograph
proven
pneumonia
recov
discharg
averag
hospitalis
patient
signific
underli
medic
problem
princip
sever
copd
chf
howev
prospect
studi
adult
age
year
hospitalis
acut
respiratori
ill
associ
variou
underli
condit
found
cultureposit
hrv
infect
mani
studi
children
adult
link
hrv
infect
exacerb
asthma
tabl
although
frequenc
hrv
detect
depend
heavili
sensit
laboratori
method
one
longitudin
studi
children
age
year
examin
relationship
exacerb
asthma
viral
infect
found
report
respiratori
ill
episod
mean
per
childyear
picornaviru
infect
detect
detect
rtpcr
proven
like
hrv
overal
viru
infect
found
report
ill
lower
respiratori
manifest
cough
wheez
short
breath
fall
peak
expiratori
flow
rate
median
delay
onset
respiratori
symptom
decreas
peak
expiratori
flow
rate
day
delay
day
present
upper
respiratori
symptom
find
indic
time
window
therapeut
intervent
prevent
exacerb
onset
respiratori
symptom
narrow
followup
analysi
document
strong
correl
season
pattern
viral
respiratori
infect
asthma
hospitalis
children
adult
upper
respiratori
ill
asthma
admiss
common
school
attend
break
peak
associ
new
school
term
hrv
infect
associ
four
peak
admiss
identifi
studi
recent
studi
asthmat
children
hospit
exacerb
two
winter
two
springsumm
season
detect
hrv
rna
nasopharyng
aspir
significantli
greater
proport
observ
frequenc
asymptomat
asthmat
children
nonasthmat
ambulatori
children
upper
respiratori
tract
ill
anoth
studi
children
less
year
age
hospitalis
wheez
found
hrv
rna
enteroviru
rna
hrv
sole
pathogen
posit
patient
common
age
month
children
hrv
infect
associ
atop
dermat
infanc
followup
approxim
year
found
possibl
associ
hrv
infect
initi
admiss
subsequ
diagnosi
earli
schoolag
asthma
studi
need
determin
whether
hrvassoci
wheez
infanc
may
associ
develop
asthma
longitudin
studi
asthmat
adult
allergi
histori
prior
hospitalis
asthma
identifi
selfdiagnos
acut
respiratori
ill
episod
object
evid
asthma
exacerb
lmin
decreas
peak
expiratori
flow
rate
pefr
cold
report
episod
lower
respiratori
symptom
cold
associ
asthma
symptom
episod
sampl
hrv
infect
detect
cultur
rtpcr
lower
respiratori
symptom
present
proven
viral
infect
pefr
decreas
lmin
last
least
day
symptom
onset
anoth
longitudin
studi
adult
asthmat
encompass
acut
respiratori
ill
associ
exacerb
found
respiratori
viral
infect
exacerb
commonli
picornaviru
follow
parainfluenza
influenza
coronaviru
relat
emerg
roombas
studi
enrol
adult
asthma
exacerb
found
patient
upper
respiratori
tract
symptom
picornavir
rna
detect
episod
picornavirus
studi
characteris
rhinovirus
studi
detect
hrv
cultur
adult
hospitalis
sever
asthma
exacerb
recent
prospect
studi
collect
nasal
aspir
everi
week
irrespect
symptom
cohabit
coupl
one
partner
asthma
hrv
rna
detect
similar
frequenc
sampl
asthmat
healthi
partner
sever
associ
upper
respiratori
tract
ill
urti
differ
group
howev
lower
respiratori
tract
ill
occur
often
asthmat
versu
follow
first
hrv
infect
greater
averag
decrement
pefr
find
indic
asthmat
adult
suscept
hrv
infect
like
develop
lower
respiratori
ill
likelihood
wheez
follow
hrv
infect
appear
depend
host
factor
includ
age
presenc
allergi
well
sever
acut
respiratori
ill
acut
respiratori
ill
associ
airway
obstruct
one
studi
asthmat
children
found
hrv
infect
associ
wheez
sever
hrvassoci
ill
correl
occurr
asthma
attack
emerg
roombas
studi
wheez
children
found
hrv
infect
detect
cultur
somewhat
less
often
less
year
old
episod
older
year
episod
age
year
older
presenc
ige
antibodi
inhal
allergen
import
risk
factor
particularli
conjunct
viral
infect
followup
studi
also
determin
hrv
infect
significantli
associ
episod
children
age
year
older
viral
rna
detect
compar
control
older
group
children
odd
ratio
wheez
much
higher
combin
rtpcr
posit
presenc
ige
aeroallergen
radioallergosorb
test
rast
nasal
eosinophilia
elev
nasal
eosinophil
cation
protein
adult
experiment
infect
hrv
significantli
greater
chang
airway
respons
inhal
histamin
observ
volunt
allergi
compar
healthi
control
subject
gener
show
chang
reactiv
observ
consist
concept
hrv
infect
potenti
preexist
airway
inflamm
asthmat
mechan
respons
associ
hrv
infect
asthma
exacerb
f
g
hayden
f
g
hayden
incomplet
defin
part
relat
wide
varieti
inflammatori
mediat
produc
airway
epitheli
cell
respons
viral
infect
review
one
histolog
hallmark
asthma
eosinophil
infiltr
experiment
hrv
infect
asthmat
otherwis
healthi
person
eosinophil
infiltr
found
bronchial
mucosa
day
infect
although
anoth
studi
find
increas
eosinophil
nonatop
contrast
healthi
subject
asthma
continu
show
eosinophil
infiltr
repeat
biopsi
week
infect
chemokin
may
play
critic
role
eosinophil
neutrophil
recruit
activ
hrvassoci
asthma
exacerb
asthmat
children
virusinduc
exacerb
predomin
due
hrv
infect
increas
nasal
lavag
level
neutrophil
myeloperoxidas
correl
sever
upper
respiratori
symptom
similarli
increas
nasal
lavag
level
correl
bronchial
hyperreact
experiment
hrv
infect
asthmat
adult
observ
suggest
might
target
therapeut
intervent
viral
infect
also
potenti
inflammatori
bronchoconstrict
respons
inhal
allergen
allerg
subject
experiment
infect
hrv
develop
immedi
late
allerg
respons
increas
bal
histamin
concentr
segment
allergen
challeng
contrast
uninfect
subject
without
allergi
bronchoconstrict
also
follow
alter
neural
control
includ
enhanc
parasympathet
respons
mechan
viral
infect
may
caus
reduc
activ
enzymeneutr
endopeptidas
inactiv
tachykinin
group
peptid
transmitt
produc
sensori
nerv
result
bronchoconstrict
increas
vascular
permeabl
glandular
secret
leukocyt
influx
airway
parasympathet
neuron
also
produc
eotaxin
attract
eosinophil
infect
augment
vagal
mediat
bronchoconstrict
multipl
mechan
includ
inhibit
express
action
muscarin
receptor
inhibitori
receptor
mediat
constrict
major
basic
protein
eosinophil
also
block
function
receptor
respect
treatment
corticosteroid
increas
receptor
activ
topic
anticholinerg
specif
ipratropium
bromid
provid
therapeut
benefit
acut
exacerb
howev
one
placebocontrol
studi
schoolag
asthmat
atop
children
found
prophylact
benefit
inhal
corticosteroid
amelior
episod
reduc
expiratori
flow
lower
respiratori
tract
ill
month
dose
viral
aetiolog
studi
determin
studi
anoth
placebocontrol
studi
inhal
corticosteroid
prophylaxi
small
number
atop
adult
found
signific
effect
number
inflammatori
cell
bronchial
biopsi
specimen
follow
experiment
hrv
infect
inform
clinic
virolog
effect
inhal
oral
corticosteroid
hrvassoci
exacerb
asthma
need
approxim
onehalf
copd
exacerb
associ
cold
pharyng
wide
dispar
exist
hrv
detect
rate
among
studi
examin
acut
respiratori
ill
exacerb
copd
differ
relat
part
differ
virolog
method
popul
studi
older
prospect
studi
copd
patient
employ
viru
cultur
mean
hrv
detect
found
approxim
exacerb
associ
hrv
infect
one
trial
collect
nasal
wash
throat
swab
monthli
time
respiratori
ill
chronic
bronchiti
patient
control
subject
hrv
infect
found
sampl
acut
respiratori
ill
respect
group
sampl
period
quiescenc
respect
exacerb
occur
bronchit
respiratori
ill
exacerb
associ
upper
respiratori
symptom
result
indic
patient
chronic
bronchiti
suscept
hrv
infect
infect
like
associ
lower
respiratori
tract
symptom
conclus
support
compar
find
copd
asthma
patient
discuss
similar
studi
patient
moder
sever
obstruct
airway
diseas
employ
prospect
cultur
throat
sampl
clinic
visit
rhinoviru
lower
respiratori
tract
rhinoviru
lower
respiratori
tract
found
hrv
recov
exacerb
hrv
isol
associ
exacerb
anoth
prospect
studi
patient
copd
cultur
rhinovirus
ill
studi
make
common
viru
identifi
found
hrv
isol
associ
ill
hrv
infect
associ
cough
episod
unlik
influenza
deterior
forc
expiratori
volum
fev
measur
recent
studi
adult
copd
utilis
serolog
cultur
viru
averag
month
followup
period
found
respiratori
ill
common
copd
ill
less
often
associ
proven
viral
infect
control
ari
picornavirus
account
document
viral
infect
copd
control
respect
one
hospitalis
associ
hrv
infect
one
year
prospect
studi
moderatesever
copd
patient
found
exacerb
associ
common
cold
sore
throat
onset
presenc
cold
symptom
onset
exacerb
associ
signific
decreas
pefr
protract
recoveri
exacerb
return
baselin
lung
function
week
followup
corticosteroid
antibiot
therapi
appear
benefit
rate
pefr
recoveri
neither
significantli
affect
symptom
recoveri
followup
studi
utilis
rtpcr
hrv
detect
found
exacerb
associ
cold
occur
day
beforehand
hrv
detect
exacerb
identifi
viral
infect
viral
infect
associ
slower
recoveri
time
median
versu
day
higher
plasma
fibrinogen
level
episod
without
viru
detect
cold
associ
protract
recoveri
corticosteroid
propos
earli
treatment
copd
exacerb
associ
cold
howev
corticosteroid
also
shown
enhanc
hrv
replic
upper
respiratori
tract
cold
import
assess
whether
use
affect
hrv
replic
lower
airway
exacerb
preexist
airway
diseas
studi
reli
cell
cultur
isol
detect
low
frequenc
viral
infect
cystic
fibrosi
patient
possibl
relat
technic
difficulti
recov
viru
tenaci
mucoid
secret
contrast
prospect
studi
cystic
fibrosi
patient
median
age
year
detect
hrv
nasopharyng
aspir
rtpcr
associ
exacerb
studi
proven
viral
aetiolog
dual
infect
anoth
respiratori
viru
found
five
instanc
hrv
infect
associ
significantli
greater
durat
intraven
antibiot
therapi
differ
pulmonari
function
test
compar
without
detect
viral
infect
anoth
prospect
studi
cold
children
cystic
fibrosi
median
age
year
found
picornaviru
rna
detect
nasal
pharyng
swab
sampl
cold
approxim
sampl
episod
shown
due
hrv
infect
decrement
spirometr
valu
compar
picornavirusand
nonpicornavirusassoci
episod
children
frequent
cold
evid
rapid
diseas
progress
new
bacteri
infect
associ
cold
increas
evid
also
indic
hrv
infect
associ
lower
respiratori
tract
involv
sever
diseas
iatrogen
immunocompromis
host
particularli
transplant
recipi
retrospect
analysi
virusposit
bal
bronchial
biopsi
cultur
period
academ
medic
centr
identifi
hrvposit
hrv
repres
third
common
viru
detect
cmv
posit
sampl
hsv
posit
occur
hospitalis
patient
age
year
acut
respiratori
ill
abnorm
chest
radiograph
presenc
immunosuppress
condit
includ
solid
organ
transplant
malign
aid
andor
immunosuppress
therapi
leukopenia
present
one
lung
transplant
recipi
intermitt
recoveri
hrv
respiratori
sampl
period
although
attempt
detect
hrv
rna
f
g
hayden
f
g
hayden
bronchial
biopsi
unsuccess
pathogen
detect
patient
includ
fungi
bacteria
virus
histopatholog
abnorm
found
seven
biopsi
two
biopsi
patient
without
recognis
infect
show
acut
inflamm
fibropurul
debri
alveoli
detect
hrv
associ
poor
prognosi
patient
care
intens
care
unit
die
hospitalis
find
suggest
hrv
infect
could
associ
sever
lower
respiratori
tract
diseas
highli
immunocompromis
patient
frequenc
hrv
infect
risk
factor
lower
respiratori
tract
diseas
transplant
recipi
well
characteris
prospect
studi
marrow
stem
cell
transplant
patient
identifi
patient
hrv
infect
repres
onequart
commun
respiratori
viral
infect
bal
perform
routin
radiograph
evid
pneumonia
instanc
isol
obtain
upper
respiratori
tract
one
bal
posit
hrv
find
suggest
hrv
infect
rare
caus
lower
respiratori
tract
diseas
although
time
infect
relat
transplant
delin
studi
lung
transplant
recipi
obtain
routin
bal
specimen
transplant
found
six
seven
patient
hrv
detect
symptom
free
although
three
evid
reject
organis
pneumonia
contrast
anoth
prospect
studi
adult
blood
marrow
transplant
recipi
undergo
condit
myelosuppress
engraft
identifi
hrv
infect
among
approxim
person
undergo
transplant
hrv
infect
account
person
acut
respiratori
ill
present
manifest
upper
respiratori
ill
within
day
transplant
infect
nosocomi
acquir
follow
day
hospitalis
ill
occur
sporad
throughout
year
without
season
predomin
patient
ill
remain
uncompl
although
associ
high
frequenc
fever
last
averag
day
seven
patient
infect
complic
pneumonia
death
due
progress
respiratori
failur
fever
wheez
dyspnoea
common
patient
mean
time
onset
respiratori
symptom
ventilatori
support
day
rang
day
hrv
cultur
antemortem
bal
tracheal
aspir
six
seven
patient
five
autopsi
four
show
find
consist
viral
pneumonia
includ
interstiti
pneumon
andor
acut
respiratori
distress
syndrom
diffus
alveolar
damag
congest
hyalin
membran
one
autopsi
reveal
invas
aspergillosi
four
found
pathogen
lung
although
three
four
seriou
infect
antemortem
import
issu
patient
extent
chemotherapyor
radiationinduc
pulmonari
damag
andor
myelosuppress
might
predispos
develop
pneumonia
although
find
suggest
infect
earli
posttranspl
increas
risk
unfavour
outcom
recent
retrospect
analysi
marrow
transplant
recipi
pneumonia
one
respiratori
season
identifi
eight
bal
sampl
test
six
patient
posit
hrv
rna
rtpcr
sampl
collect
averag
day
posttranspl
indic
almost
commun
acquir
infect
two
patient
repeat
bal
sampl
posit
interv
day
initi
posit
one
rais
possibl
prolong
lower
respiratori
tract
replic
fatal
rate
hrvinfect
patient
signific
coinfect
mean
time
respiratori
ill
onset
death
day
autopsi
data
obtain
avail
evid
indic
hrv
may
associ
lower
respiratori
tract
diseas
highli
immunocompromis
marrow
transplant
recipi
frequent
coinfect
often
poor
prognosi
howev
contribut
hrv
overal
pathogenesi
remain
uncertain
regard
caus
direct
viral
damag
predisposit
secondari
invad
time
infect
relat
transplant
type
transplant
may
import
variabl
regard
sever
diseas
data
need
hsct
solid
organ
particularli
lung
transplant
recipi
rhinoviru
lower
respiratori
tract
rhinoviru
lower
respiratori
tract
implic
antivir
use
consider
burden
hrv
infect
respect
upper
lower
respiratori
tract
disord
highlight
medic
need
effect
intervent
unfortun
safe
effect
hrvspecif
antivir
agent
current
avail
treatment
prevent
hrv
ill
import
limit
avail
data
regard
hrv
infect
target
popul
lack
inform
regard
viral
dynam
specif
quantit
infecti
viral
level
differ
site
upper
versu
lower
respiratori
tract
time
point
ill
consequ
import
ongo
viral
replic
diseas
pathogenesi
defin
lower
respiratori
syndrom
associ
hrv
regard
control
studi
select
antivir
agent
would
help
assess
contribut
hrv
infect
lower
respiratori
tract
diseas
mani
target
group
prevent
hrv
infect
antivir
chemoprophylaxi
control
measur
eg
handwash
would
expect
reduc
risk
lower
respiratori
tract
ill
particularli
underli
condit
contrast
given
short
time
onset
cold
exacerb
preexist
airway
diseas
unclear
whether
earli
treatment
could
prevent
exacerb
whether
antivir
treatment
might
modifi
establish
exacerb
asthma
copd
would
depend
heavili
extent
hrv
replic
role
promot
deleteri
host
respons
combin
antivir
intervent
direct
host
respons
would
seem
offer
highest
likelihood
therapeut
success
treatment
studi
antihrv
agent
infant
young
children
immunocompromis
host
could
provid
import
data
regard
role
hrv
infect
caus
viral
pneumonia
well
potenti
provid
clinic
benefit
among
investig
antivir
studi
past
review
refer
intranas
interferon
proven
prophylact
efficaci
natur
hrv
infect
howev
intranas
interferon
associ
mucos
intoler
prolong
use
therapeut
effect
establish
hrv
cold
nasal
applic
antivir
protect
immunocompet
adult
remain
determin
whether
deliveri
lower
respiratori
tract
import
prophylact
efficaci
preexist
airway
disord
current
two
investig
antihrv
agent
oral
administ
capsidbind
pleconaril
topic
appli
proteas
inhibitor
ruprintrivir
candid
use
pleconaril
first
antivir
proven
effect
treat
hrv
cold
otherwis
healthi
adult
addit
pleconaril
use
treat
sever
sever
enteroviru
infect
one
hrv
infect
marrow
transplant
patient
report
clinic
improv
avail
compassion
use
basi
